BioCentury
ARTICLE | Distillery Therapeutics

Neurology

September 11, 2017 7:27 PM UTC

Mouse studies suggest inhibiting RPS6KB1 could help treat SCI. In a mouse model of SCI, intracortical injection of a selective RPS6KB1 inhibitor tool compound increased regeneration of the cortico-spinal tract axons and sensorimotor function compared with vehicle. Next steps could include testing additional RPS6KB1 inhibitors in SCI models...